{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:38:07Z","timestamp":1794530287072,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41423-018-0006-2","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T17:02:03Z","timestamp":1520614923000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Type III interferon-induced CBF\u03b2 inhibits HBV replication by hijacking HBx"],"prefix":"10.1038","volume":"16","author":[{"given":"Fengchao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557\u20132576 (2007).","journal-title":"Gastroenterology"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero, M. & Zucman-Rossi, J. Mechanisms of HBV-induced hepatocellular carcinoma. J. Hepatol. 64, S84\u2013S101 (2016).","journal-title":"J. Hepatol."},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095\u20132128 (2012).","journal-title":"Lancet"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal, M. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64, 1972\u20131984 (2015).","journal-title":"Gut"},{"key":"6_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/v5051261","volume":"5","author":"DY Gong","year":"2013","unstructured":"Gong, D. Y. et al. Role and functional domain of hepatitis Bvirus X protein in regulating HBV transcription and replication in vitro and in vivo. Viruses 5, 1261\u20131271 (2013).","journal-title":"Viruses"},{"key":"6_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2012.01.021","volume":"426","author":"AJ Hodgson","year":"2012","unstructured":"Hodgson, A. J., Hyser, J. M., Keasler, V. V., Cang, Y. & Slagle, B. L. Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology 426, 73\u201382 (2012).","journal-title":"Virology"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","volume":"16","author":"CM Murphy","year":"2016","unstructured":"Murphy, C. M. et al. Hepatitis B Virus X protein promotes degradation of SMC5\/6 to enhance HBV replication. Cell Rep. 16, 2846\u20132854 (2016).","journal-title":"Cell Rep."},{"issue":"4","key":"6_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/v9040069","volume":"9","author":"Christine Livingston","year":"2017","unstructured":"Livingston C. M., Ramakrishnan D., Strubin M., Fletcher S. P., Beran R. K. Identifying and characterizing interplay between Hepatitis B Virus X protein and Smc5\/6. Viruses. 9, 69 (2017).","journal-title":"Viruses"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"A41","DOI":"10.1053\/ejpn.2002.0573","volume":"6","author":"M Andrea De","year":"2002","unstructured":"De Andrea, M., Ravera, R., Gioia, D., Gariglio, M. & Landolfo, S. The interferon system: an overview. Eur. J. Paediatr. Neurol. 6, A41\u2013A46 (2002). Discussion A55\u201348.","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3389\/fimmu.2017.00749","volume":"8","author":"S Lee","year":"2017","unstructured":"Lee, S. & Baldridge, M. T. Interferon-lambda: a potent regulator of intestinal viral infections. Front. Immunol. 8, 749 (2017).","journal-title":"Front. Immunol."},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","volume":"357","author":"J Parkin","year":"2001","unstructured":"Parkin, J. & Cohen, B. An overview of the immune system. Lancet 357, 1777\u20131789 (2001).","journal-title":"Lancet"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.virol.2013.06.028","volume":"444","author":"T Pollicino","year":"2013","unstructured":"Pollicino, T. et al. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology 444, 317\u2013328 (2013).","journal-title":"Virology"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1128\/JVI.77.2.1227-1236.2003","volume":"77","author":"SF Wieland","year":"2003","unstructured":"Wieland, S. F. et al. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J. Virol. 77, 1227\u20131236 (2003).","journal-title":"J. Virol."},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.22751","volume":"49","author":"J Wu","year":"2009","unstructured":"Wu, J. et al. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49, 1132\u20131140 (2009).","journal-title":"Hepatology"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbrc.2016.03.082","volume":"473","author":"F Xu","year":"2016","unstructured":"Xu, F., Song, H., Li, N. & Tan, G. HBsAg blocks TYPE I IFN induced up-regulation of A3G through inhibition of STAT3. Biochem. Biophys. Res. Commun. 473, 219\u2013223 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1128\/JVI.02760-14","volume":"89","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways. J. Virol. 89, 2287\u20132300 (2015).","journal-title":"J. Virol."},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/cmi.2017.1","volume":"14","author":"Y Wan","year":"2017","unstructured":"Wan, Y. et al. Inducible Rubicon facilitates viral replication by antagonizing interferon production. Cell. Mol. Immunol. 14, 607\u2013620 (2017).","journal-title":"Cell. Mol. Immunol."},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ni873","volume":"4","author":"P Sheppard","year":"2003","unstructured":"Sheppard, P. et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4, 63\u201368 (2003).","journal-title":"Nat. Immunol."},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","volume":"42","author":"S Sato","year":"2015","unstructured":"Sato, S. et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123\u2013132 (2015).","journal-title":"Immunity"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.virusres.2007.03.006","volume":"126","author":"SH Hong","year":"2007","unstructured":"Hong, S. H. et al. Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells. Virus Res. 126, 245\u2013249 (2007).","journal-title":"Virus Res."},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.virol.2010.02.022","volume":"401","author":"NE Pagliaccetti","year":"2010","unstructured":"Pagliaccetti, N. E., Chu, E. N., Bolen, C. R., Kleinstein, S. H. & Robek, M. D. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401, 197\u2013206 (2010).","journal-title":"Virology"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature10693","volume":"481","author":"S Jager","year":"2011","unstructured":"Jager, S. et al. Vif hijacks CBF-beta to degrade APOBEC3G and promote HIV-1 infection. Nature 481, 371\u2013375 (2011).","journal-title":"Nature"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature10718","volume":"481","author":"W Zhang","year":"2011","unstructured":"Zhang, W., Du, J., Evans, S. L., Yu, Y. & Yu, X. F. T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481, 376\u2013379 (2011).","journal-title":"Nature"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/scdb.2000.0189","volume":"11","author":"N Adya","year":"2000","unstructured":"Adya, N., Castilla, L. H. & Liu, P. P. Function of CBFbeta\/Bro proteins. Semin. Cell. Dev. Biol. 11, 361\u2013368 (2000).","journal-title":"Semin. Cell. Dev. Biol."},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1038\/sj.onc.1207763","volume":"23","author":"MF Bruijn de","year":"2004","unstructured":"de Bruijn, M. F. & Speck, N. A. Core-binding factors in hematopoiesis and immune function. Oncogene 23, 4238\u20134248 (2004).","journal-title":"Oncogene"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"E1264","DOI":"10.1073\/pnas.1320071111","volume":"111","author":"D Yang","year":"2014","unstructured":"Yang, D. et al. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line. Proc. Natl. Acad. Sci. USA 111, E1264\u2013E1273 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"33036","DOI":"10.1074\/jbc.M112.383273","volume":"287","author":"G Tan","year":"2012","unstructured":"Tan, G., Niu, J., Shi, Y., Ouyang, H. & Wu, Z. H. NF-kappaB-dependent microRNA-125b up-regulation promotes cell survival by targeting p38alpha upon ultraviolet radiation. J. Biol. Chem. 287, 33036\u201333047 (2012).","journal-title":"J. Biol. Chem."},{"key":"6_CR28","doi-asserted-by":"crossref","unstructured":"Tan G. et al. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication. Cell Mol Immunol PMID:28194021, DOI:10.1038\/cmi.2016.67 (2017).","DOI":"10.1038\/cmi.2016.67"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","volume":"38","author":"SY Liu","year":"2013","unstructured":"Liu, S. Y. et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38, 92\u2013105 (2013).","journal-title":"Immunity"},{"key":"6_CR30","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.4049\/jimmunol.1002041","volume":"185","author":"SS Iyer","year":"2010","unstructured":"Iyer, S. S., Ghaffari, A. A. & Cheng, G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. J. Immunol. 185, 6599\u20136607 (2010).","journal-title":"J. Immunol."},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1126\/science.1083653","volume":"300","author":"T Pawson","year":"2003","unstructured":"Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science 300, 445\u2013452 (2003).","journal-title":"Science"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrm.2016.30","volume":"17","author":"F Uhlmann","year":"2016","unstructured":"Uhlmann, F. SMC complexes: from DNA to chromosomes. Nat. Rev. Mol. Cell. Biol. 17, 399\u2013412 (2016).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"6_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsiere","year":"2016","unstructured":"Decorsiere, A. et al. Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature 531, 386\u2013389 (2016).","journal-title":"Nature"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.","year":"2012","unstructured":"European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J. Hepatol. 57, 167\u2013185 (2012).","journal-title":"J. Hepatol."},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fimmu.2017.00621","volume":"8","author":"S Phillips","year":"2017","unstructured":"Phillips, S. et al. Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients. Front. Immunol. 8, 621 (2017).","journal-title":"Front. Immunol."},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3389\/fimmu.2017.00989","volume":"8","author":"N Sopel","year":"2017","unstructured":"Sopel, N., Pflaum, A., Kolle, J. & Finotto, S. The Unresolved Role of Interferon-lambda in Asthma Bronchiale. Front. Immunol. 8, 989 (2017).","journal-title":"Front. Immunol."},{"key":"6_CR37","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/hep.21312","volume":"44","author":"SE Doyle","year":"2006","unstructured":"Doyle, S. E. et al. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 44, 896\u2013906 (2006).","journal-title":"Hepatology"},{"key":"6_CR38","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","volume":"79","author":"MD Robek","year":"2005","unstructured":"Robek, M. D., Boyd, B. S. & Chisari, F. V. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol. 79, 3851\u20133854 (2005).","journal-title":"J. Virol."},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko, S. V. et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4, 69\u201377 (2003).","journal-title":"Nat. Immunol."},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1073\/pnas.0401771101","volume":"101","author":"S Wieland","year":"2004","unstructured":"Wieland, S., Thimme, R., Purcell, R. H. & Chisari, F. V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 101, 6669\u20136674 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6_CR41","doi-asserted-by":"crossref","unstructured":"Cheng X. et al. Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages. Hepatology. 66, 1779\u20131793, doi: 10.1002\/hep.29348 (2017).","DOI":"10.1002\/hep.29348"},{"key":"6_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jmv.24643","volume":"89","author":"S Tsunematsu","year":"2017","unstructured":"Tsunematsu, S. et al. Hepatitis B virus X protein impairs alpha-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A. J. Med. Virol. 89, 267\u2013275 (2017).","journal-title":"J. Med. Virol."},{"key":"6_CR43","doi-asserted-by":"crossref","unstructured":"Gao Y. et al. HBx-elevated MSL2 Modulates HBV cccDNA through Inducing Degradation of APOBEC3B to Enhance Hepatocarcinogenesis. Hepatology. 66, 1413\u20131429, doi: 10.1002\/hep.29316 (2017).","DOI":"10.1002\/hep.29316"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrc3877","volume":"15","author":"Y Ito","year":"2015","unstructured":"Ito, Y., Bae, S. C. & Chuang, L. S. The RUNX family: developmental regulators in cancer. Nat. Rev. Cancer 15, 81\u201395 (2015).","journal-title":"Nat. Rev. Cancer"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0006-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-018-0006-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:20:37Z","timestamp":1684617637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-018-0006-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1038\/s41423-018-0006-2","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"25 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}